Literature DB >> 3318824

Improvement of cytotoxicity of tumor necrosis factor (TNF) by increase in basicity of its N-terminal region.

G Soma1, N Kitahara, Y Tsuji, M Kato, H Oshima, T Gatanaga, H Inagawa, K Noguchi, Y Tanabe, D Mizuno.   

Abstract

Two new recombinant TNFs (named rTNF-Scw1 and -Scw2) with higher basicity than conventional recombinant human TNF-alpha (rTNF-alpha) in the N-terminal region were constructed. Their sequences were constructed based on those of partially purified cytotoxic factors from the culture supernatant of acute monocytic leukemia cells THP-1, which unlike rTNF-alpha are cytotoxic to T24 bladder carcinoma cells in vitro. These new rTNF-Ss showed a broader cytotoxicity to tumor cells than rTNF-alpha. This increase in the basicity of the N-terminal region over that of conventional TNF significantly increased the cytotoxicity on tumor cells in vivo as well as in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318824     DOI: 10.1016/0006-291x(87)90923-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity.

Authors:  Meng Li; Xin Qin; Xiaochang Xue; Cun Zhang; Zhen Yan; Wei Han; Chris Komarck; Thomas D Wang; Yingqi Zhang
Journal:  Anticancer Drugs       Date:  2010-03       Impact factor: 2.248

2.  Human lymphotoxin mutein lacks hypotensive activity but has higher in vivo antitumor activity than lymphotoxin or tumor necrosis factor.

Authors:  M Taniyama; T Morita; Y Yamagishi; A Kato; C Bando; N Okawa; A Kaji
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis.

Authors:  X Van Ostade; J Tavernier; T Prangé; W Fiers
Journal:  EMBO J       Date:  1991-04       Impact factor: 11.598

4.  The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.

Authors:  H Tchorzewski; K Zeman; J Kantorski; E Paleolog; M Kahan; M Feldmann; M Kwinkowski; P Guga; B Szymanska; P Parniewski; A Wilk; J Jarosz
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

5.  A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice.

Authors:  K Warzocha; J Góra-Tybor; M Kwinkowski; B Szymańska; T Robak
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

6.  Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity.

Authors:  T Masegi; A Kato; K Kitai; M Fukuoka; H Ogawa; Y Ichikawa; S Nakamura; N Watanabe; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1995-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.